Prachi C Jog, MD
Nephrology · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 052555 · 052629 · 552725 · Dominican Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jog’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A121507 · Current
Licensed to practise in California · since 2012 · expires 2028-04-30 · University of Pune, B. J. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$240,689
Medicare paid this office $240,689 for 518 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 36 | $55,956 | $291 |
| Return visit (30+ min) | 228 | $49,334 | $99 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $42,202 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $41,266 | $96 |
| Short return visit (20+ min) | 139 | $12,419 | $66 |
See all 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 36 | $55,956 | $291 |
| Return visit (30+ min) | 228 | $49,334 | $99 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $42,202 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $41,266 | $96 |
| Short return visit (20+ min) | 139 | $12,419 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $8,483 | $105 |
| New patient visit (45+ min) | 40 | $4,704 | $118 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 21 | $4,431 | $5 |
| New patient visit (30+ min) | 19 | $1,645 | $87 |
| Hemodialysis procedure with physician evaluation | 14 | $805 | $58 |
| Injection of drug or substance under skin or into muscle | 19 | $704 | $12 |
| Automated urinalysis test | 15 | $33 | $2 |
Who their Medicare patients are
518 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 20% · Women 45% · Also on Medicaid 31% · Health risk score 3.26. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 49% · Heart failure 44% · Coronary heart disease 40% · Atrial fibrillation 37% · Depression 24% · COPD 17% · Cancer 16% · Stroke 10% · Dementia 9%.
The office billed $980,179, Medicare allowed $313,490 and paid $240,689; for 2,643 services of 24 kinds; $4,571 of it was for drugs given in the office and $236,119 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 518 | 2,643 | 75 | 3.26 | $980,179 | $240,689 |
| 2023 | 566 | 2,759 | 75 | 3.45 | $1,117,658 | $299,961 |
| 2022 | 552 | 2,850 | 74 | 3.28 | $1,094,844 | $298,683 |
| 2021 | 490 | 2,429 | 74 | 3.30 | $968,495 | $266,543 |
| 2020 | 407 | 2,268 | 73 | 3.55 | $755,373 | $180,377 |
| 2019 | 528 | 3,642 | 73 | 3.53 | $1,206,396 | $290,058 |
| 2018 | 503 | 3,246 | 73 | 3.48 | $1,065,276 | $258,509 |
| 2017 | 505 | 4,263 | 72 | 3.47 | $905,291 | $227,456 |
| 2016 | 474 | 3,482 | 72 | 3.04 | $853,456 | $214,421 |
| 2015 | 389 | 2,378 | 72 | 3.06 | $653,451 | $171,705 |
| 2014 | 288 | 1,294 | 71 | 2.73 | $379,328 | $96,604 |
| 2013 | 190 | 789 | 71 | 2.95 | $269,513 | $66,168 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 56 | $107,417 | $259 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $49,519 | $100 |
| Return visit (30+ min) | 217 | $48,607 | $106 |
| Home dialysis services per month (20 years or older) | 11 | $21,153 | $261 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $18,125 | $179 |
| Short return visit (20+ min) | 165 | $15,303 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 83 | $10,684 | $110 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $9,971 | $312 |
| New patient visit (45+ min) | 42 | $5,761 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $4,364 | $67 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 19 | $3,002 | $6 |
| New patient visit (30+ min) | 13 | $1,283 | $99 |
| Injection of drug or substance under skin or into muscle | 20 | $581 | $13 |
| Automated urinalysis test | 22 | $48 | $2 |
2022: 14 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 65 | $97,579 | $263 |
| Return visit (30+ min) | 232 | $51,778 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $47,595 | $89 |
| Home dialysis services per month (20 years or older) | 13 | $23,792 | $267 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $15,573 | $171 |
| Short return visit (20+ min) | 165 | $15,531 | $67 |
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $13,805 | $182 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $12,671 | $317 |
| New patient visit (45+ min) | 46 | $6,014 | $131 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 13 | $3,198 | None |
| New patient visit (30+ min) | 14 | $1,258 | $90 |
| Hemodialysis procedure with physician evaluation | 11 | $687 | $62 |
| Injection of drug or substance under skin or into muscle | 15 | $630 | $13 |
| Automated urinalysis test | 40 | $89 | $2 |
2021: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 35 | $58,746 | $312 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $53,174 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $40,460 | $89 |
| Return visit (30+ min) | 130 | $27,128 | $110 |
| Short return visit (20+ min) | 203 | $22,250 | $71 |
| New patient visit (45+ min) | 96 | $12,845 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,724 | $172 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $5,367 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,555 | $60 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 11 | $2,737 | None |
| Hemodialysis procedure with physician evaluation | 23 | $2,007 | $63 |
| Injection of drug or substance under skin or into muscle | 12 | $385 | $13 |
| Automated urinalysis test | 54 | $122 | $2 |
2020: 15 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 51 | $50,162 | $208 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $24,775 | $248 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $20,082 | $89 |
| Home dialysis services per month (20 years or older) | 11 | $16,426 | $203 |
| Short return visit (20+ min) | 177 | $15,182 | $55 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $10,605 | $161 |
| Return visit (30+ min) | 72 | $10,054 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,554 | $168 |
| New patient visit (45+ min) | 52 | $7,006 | $135 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 17 | $5,930 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,355 | $64 |
| Hemodialysis procedure with physician evaluation | 27 | $2,213 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,262 | $63 |
| Injection of drug or substance under skin or into muscle | 17 | $665 | $13 |
| Automated urinalysis test | 21 | $47 | $2 |
2019: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $73,092 | $243 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 55 | $43,340 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $36,152 | $88 |
| Short return visit (20+ min) | 244 | $28,838 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $22,068 | $170 |
| Return visit (30+ min) | 125 | $21,466 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $12,370 | $62 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 27 | $10,767 | None |
| New patient visit (45+ min) | 70 | $9,206 | $132 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $6,517 | $159 |
| Hemodialysis procedure with physician evaluation | 47 | $4,901 | $62 |
| Injection of drug or substance under skin or into muscle | 26 | $1,162 | $14 |
| Automated urinalysis test | 32 | $78 | $2 |
2018: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $48,329 | $236 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 68 | $45,130 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 134 | $39,077 | $86 |
| Return visit (30+ min) | 139 | $27,174 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $21,790 | $163 |
| Short return visit (20+ min) | 207 | $20,296 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $10,327 | $60 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 17 | $9,432 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $8,339 | $154 |
| New patient visit (45+ min) | 56 | $7,270 | $130 |
| Critical care, first 30-74 minutes | 15 | $5,088 | $182 |
| Hemodialysis procedure with physician evaluation | 36 | $3,057 | $60 |
| Injection of drug or substance under skin or into muscle | 17 | $1,197 | $18 |
| Manual urinalysis test with examination using microscope, automated | 51 | $196 | $4 |
2017: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $36,223 | $84 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $28,001 | $231 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $27,974 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $24,561 | $161 |
| Return visit (30+ min) | 125 | $22,371 | $82 |
| Short return visit (20+ min) | 222 | $21,090 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $19,212 | $59 |
| New patient visit (45+ min) | 73 | $8,680 | $119 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 16 | $8,050 | None |
| Dialysis services, per day, less than full month service (20 years or older) | 28 | $7,778 | $6 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $4,538 | $151 |
| Hemodialysis procedure with physician evaluation | 31 | $2,651 | $59 |
| Injection of drug or substance under skin or into muscle | 17 | $1,462 | $21 |
| Manual urinalysis test with examination using microscope, automated | 77 | $326 | $4 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $36,802 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $22,356 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $22,339 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $22,052 | $58 |
| Short return visit (20+ min) | 201 | $20,475 | $54 |
| Return visit (30+ min) | 119 | $20,398 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $17,104 | $192 |
| New patient visit (45+ min) | 100 | $13,260 | $133 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $4,489 | $6 |
| Critical care, first 30-74 minutes | 18 | $4,476 | $179 |
| Hemodialysis procedure with physician evaluation | 34 | $3,297 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,550 | $103 |
| Manual urinalysis test with examination using microscope, automated | 95 | $409 | $4 |
2015: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $32,025 | $243 |
| Return visit (30+ min) | 122 | $22,454 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $22,161 | $61 |
| Short return visit (20+ min) | 160 | $14,917 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $14,013 | $89 |
| New patient visit (45+ min) | 92 | $12,394 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,347 | $172 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $9,622 | $205 |
| Hemodialysis procedure with physician evaluation | 49 | $4,938 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,793 | $117 |
| Critical care, first 30-74 minutes | 19 | $4,049 | $184 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $3,570 | $7 |
| Manual urinalysis test with examination using microscope, automated | 82 | $367 | $4 |
2014: 11 services
| Return visit (30+ min) | 89 | $15,832 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $15,010 | $58 |
| Short return visit (20+ min) | 119 | $11,270 | $52 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $10,563 | $225 |
| New patient visit (45+ min) | 74 | $9,770 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,700 | $106 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $6,395 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,870 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,923 | $163 |
| Hemodialysis procedure with physician evaluation | 21 | $3,712 | $58 |
| Manual urinalysis test with examination using microscope, automated | 83 | $372 | $4 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $17,431 | $56 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $12,471 | $227 |
| New patient visit (45+ min) | 59 | $7,541 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $6,489 | $106 |
| Short return visit (20+ min) | 63 | $5,876 | $58 |
| Return visit (30+ min) | 36 | $3,374 | $80 |
| Hemodialysis procedure with physician evaluation | 19 | $3,075 | $57 |
| Critical care, first 30-74 minutes | 11 | $2,768 | $173 |
| Automated urinalysis test | 23 | $70 | $3 |
Medicaid work
$30,764 in 2024
Medicaid paid $30,764 for 333 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 107 | $13,906 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 71 | $9,651 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 130 | $6,229 |
| Return visit (30+ min) | 25 | $978 |
| 2024 | 333 | 4 | 24 | $30,764 |
| 2023 | 804 | 6 | 35 | $71,087 |
| 2022 | 784 | 6 | 37 | $72,965 |
| 2021 | 759 | 5 | 28 | $80,260 |
| 2020 | 446 | 6 | 36 | $46,942 |
| 2019 | 856 | 5 | 32 | $74,571 |
| 2018 | 748 | 5 | 49 | $65,951 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 341 | $47,297 |
| Return visit (30+ min) | 203 | $10,895 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 218 | $9,527 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 15 | $1,734 |
| Short return visit (20+ min) | 15 | $937 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $697 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 310 | $52,697 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 295 | $7,896 |
| Return visit (30+ min) | 128 | $5,532 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 27 | $4,570 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $1,485 |
| Short return visit (20+ min) | 12 | $785 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 182 | $33,655 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 188 | $26,473 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 249 | $14,077 |
| Return visit (30+ min) | 67 | $3,437 |
| Short return visit (20+ min) | 73 | $2,617 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 229 | $27,357 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 62 | $9,972 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 30 | $3,191 |
| Short return visit (20+ min) | 62 | $2,630 |
| Return visit (30+ min) | 30 | $1,948 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $1,845 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 280 | $38,272 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 165 | $17,060 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 169 | $8,773 |
| Short return visit (20+ min) | 183 | $6,842 |
| Return visit (30+ min) | 59 | $3,623 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 200 | $27,216 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 200 | $21,948 |
| Return visit (30+ min) | 139 | $8,108 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 106 | $5,390 |
| Short return visit (20+ min) | 103 | $3,288 |
Drugs they prescribed that Part D paid
$481,922
Pharmacies billed $481,922 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,295) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
2,068 generic and fewer than 11 brand-name prescriptions · $481,922 in drug cost · 51 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 57 | $71,153 | $1,248 |
| Velphoro | 13 | $64,887 | $4,991 |
| Veltassa | 30 | $39,010 | $1,300 |
| Sevelamer Carbonate | 121 | $34,905 | $288 |
| Lokelma | 37 | $31,774 | $859 |
See all 39 drugs
| Jardiance | 57 | $71,153 | $1,248 |
| Velphoro | 13 | $64,887 | $4,991 |
| Veltassa | 30 | $39,010 | $1,300 |
| Sevelamer Carbonate | 121 | $34,905 | $288 |
| Lokelma | 37 | $31,774 | $859 |
| Farxiga | 27 | $20,635 | $764 |
| Cinacalcet | 11 | $18,834 | $1,712 |
| Valsartan | 71 | $4,129 | $58 |
| Nifedipine Er | 53 | $3,612 | $68 |
| Torsemide | 161 | $3,488 | $22 |
| Calcium Acetate | 31 | $3,422 | $110 |
| Potassium Chloride | 52 | $2,361 | $45 |
| Tacrolimus | 17 | $2,131 | $125 |
| Hydralazine | 107 | $1,608 | $15 |
| Losartan | 133 | $1,586 | $12 |
| Clonidine | 24 | $1,513 | $63 |
| Midodrine | 31 | $1,405 | $45 |
| Carvedilol | 118 | $1,188 | $10 |
| Calcitriol | 75 | $1,108 | $15 |
| Amlodipine Besylate | 124 | $1,067 | $9 |
| Allopurinol | 127 | $943 | $7 |
| Estradiol | 16 | $906 | $57 |
| Lisinopril | 117 | $899 | $8 |
| Furosemide | 93 | $619 | $7 |
| Spironolactone | 27 | $520 | $19 |
| Lidocaine-Prilocaine | 17 | $470 | $28 |
| Doxazosin Mesylate | 32 | $339 | $11 |
| Metoprolol | 26 | $337 | $13 |
| Gabapentin | 29 | $333 | $11 |
| Mycophenolic Acid | 11 | $318 | $29 |
| Famotidine | 32 | $293 | $9 |
| Atorvastatin | 56 | $272 | $5 |
| Bumetanide | 16 | $206 | $13 |
| Losartan-Hydrochlorothiazide | 14 | $192 | $14 |
| Hydrochlorothiazide | 34 | $182 | $5 |
| Valacyclovir | 12 | $141 | $12 |
| Cephalexin | 29 | $134 | $5 |
| Clonidine | 15 | $133 | $9 |
| Ondansetron | 11 | $89 | $8 |
Year by year
| 2024 | 2,295 | 341 | 0% (0) | None | $481,922 |
| 2023 | 2,200 | 332 | None | None | $375,170 |
| 2022 | 1,944 | 302 | None | None | $315,096 |
| 2021 | 1,692 | 243 | 0% (0) | 10% | $256,194 |
| 2020 | 1,506 | 207 | None | 14% | $244,166 |
| 2019 | 1,977 | 252 | 1% (12) | None | $270,241 |
| 2018 | 1,742 | 231 | 1% (11) | 16% | $259,212 |
| 2017 | 1,423 | 190 | 1% (13) | 19% | $340,932 |
| 2016 | 1,294 | 171 | 1% (16) | 16% | $225,297 |
| 2015 | 1,080 | 148 | None | 17% | $137,387 |
| 2014 | 624 | 102 | None | None | $61,236 |
| 2013 | 197 | 52 | None | 21% | $14,967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Velphoro | 19 | $68,805 | $3,621 |
| Veltassa | 37 | $46,082 | $1,245 |
| Sevelamer Carbonate | 67 | $35,078 | $524 |
| Jardiance | 30 | $32,188 | $1,073 |
| Lokelma | 22 | $20,082 | $913 |
| Farxiga | 16 | $12,899 | $806 |
| Cinacalcet | 12 | $10,904 | $909 |
| Torsemide | 182 | $7,849 | $43 |
| Tacrolimus | 22 | $6,618 | $301 |
| Calcium Acetate | 32 | $4,968 | $155 |
| Losartan | 146 | $3,667 | $25 |
| Valsartan | 47 | $3,542 | $75 |
| Nifedipine Er | 37 | $3,311 | $89 |
| Amlodipine Besylate | 169 | $3,147 | $19 |
| Hydralazine | 104 | $2,775 | $27 |
| Clonidine | 17 | $2,770 | $163 |
| Allopurinol | 127 | $2,296 | $18 |
| Carvedilol | 115 | $2,256 | $20 |
| Lisinopril | 123 | $2,249 | $18 |
| Midodrine | 18 | $2,090 | $116 |
| Calcitriol | 86 | $1,807 | $21 |
| Potassium Chloride | 43 | $1,622 | $38 |
| Spironolactone | 40 | $1,404 | $35 |
| Furosemide | 128 | $1,398 | $11 |
| Metoprolol | 40 | $1,076 | $27 |
| Famotidine | 37 | $672 | $18 |
| Atorvastatin | 30 | $514 | $17 |
| Terazosin | 12 | $402 | $33 |
| Doxazosin Mesylate | 17 | $390 | $23 |
| Lidocaine-Prilocaine | 15 | $379 | $25 |
| Gabapentin | 33 | $340 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $264 | $19 |
| Hydrochlorothiazide | 34 | $227 | $7 |
| Lactulose | 12 | $219 | $18 |
| Cephalexin | 31 | $181 | $6 |
| Clonidine | 12 | $178 | $15 |
| Prednisone | 12 | $114 | $9 |
2022: 33 drugs
| Velphoro | 14 | $49,653 | $3,547 |
| Veltassa | 32 | $44,906 | $1,403 |
| Sevelamer Carbonate | 78 | $38,052 | $488 |
| Lanthanum Carbonate | 15 | $26,253 | $1,750 |
| Lokelma | 12 | $11,752 | $979 |
| Torsemide | 141 | $4,540 | $32 |
| Losartan | 133 | $2,422 | $18 |
| Midodrine | 27 | $1,877 | $70 |
| Calcitriol | 91 | $1,825 | $20 |
| Carvedilol | 103 | $1,825 | $18 |
| Amlodipine Besylate | 151 | $1,795 | $12 |
| Allopurinol | 107 | $1,765 | $16 |
| Hydralazine | 64 | $1,650 | $26 |
| Lisinopril | 84 | $1,520 | $18 |
| Nifedipine Er | 20 | $1,391 | $70 |
| Spironolactone | 51 | $1,358 | $27 |
| Valsartan | 25 | $1,292 | $52 |
| Potassium Chloride | 27 | $959 | $36 |
| Furosemide | 106 | $753 | $7 |
| Metoprolol | 31 | $680 | $22 |
| Clonidine | 25 | $585 | $23 |
| Atorvastatin | 34 | $572 | $17 |
| Lidocaine-Prilocaine | 19 | $541 | $28 |
| Doxazosin Mesylate | 28 | $433 | $15 |
| Lactulose | 25 | $379 | $15 |
| Amiloride | 15 | $302 | $20 |
| Levothyroxine | 20 | $277 | $14 |
| Omeprazole | 14 | $272 | $19 |
| Gabapentin | 42 | $250 | $6 |
| Hydrochlorothiazide | 34 | $218 | $6 |
| Famotidine | 32 | $218 | $7 |
| Cephalexin | 31 | $155 | $5 |
| Prednisone | 14 | $101 | $7 |
2021: 33 drugs
| Velphoro | 14 | $46,873 | $3,348 |
| Veltassa | 27 | $43,928 | $1,627 |
| Lanthanum Carbonate | 16 | $30,119 | $1,882 |
| Lokelma | 14 | $15,722 | $1,123 |
| Sevelamer Carbonate | 70 | $15,213 | $217 |
| Cinacalcet | 17 | $9,963 | $586 |
| Torsemide | 128 | $3,567 | $28 |
| Calcium Acetate | 16 | $3,057 | $191 |
| Clinisol | 18 | $2,646 | $147 |
| Calcitriol | 83 | $2,272 | $27 |
| Allopurinol | 111 | $1,865 | $17 |
| Losartan | 106 | $1,703 | $16 |
| Valsartan | 18 | $1,573 | $87 |
| Midodrine | 26 | $1,540 | $59 |
| Carvedilol | 79 | $1,482 | $19 |
| Amlodipine Besylate | 113 | $1,289 | $11 |
| Hydralazine | 43 | $1,045 | $24 |
| Nifedipine Er | 12 | $828 | $69 |
| Lisinopril | 92 | $764 | $8 |
| Potassium Chloride | 18 | $725 | $40 |
| Atorvastatin | 37 | $711 | $19 |
| Omeprazole | 21 | $533 | $25 |
| Metoprolol | 20 | $505 | $25 |
| Furosemide | 96 | $492 | $5 |
| Famotidine | 54 | $482 | $9 |
| Spironolactone | 21 | $431 | $21 |
| Hydrochlorothiazide | 40 | $417 | $10 |
| Doxazosin Mesylate | 27 | $381 | $14 |
| Levothyroxine | 18 | $367 | $20 |
| Lactulose | 17 | $348 | $20 |
| Gabapentin | 35 | $288 | $8 |
| Clonidine | 17 | $247 | $15 |
| Cephalexin | 18 | $101 | $6 |
2020: 31 drugs
| Renvela | 29 | $79,178 | $2,730 |
| Veltassa | 22 | $35,179 | $1,599 |
| Lanthanum Carbonate | 16 | $29,201 | $1,825 |
| Sevelamer Carbonate | 70 | $16,581 | $237 |
| Torsemide | 121 | $3,542 | $29 |
| Calcium Acetate | 27 | $3,011 | $112 |
| Clinisol | 11 | $2,013 | $183 |
| Nifedipine Er | 23 | $1,885 | $82 |
| Calcitriol | 69 | $1,851 | $27 |
| Allopurinol | 114 | $1,571 | $14 |
| Irbesartan | 24 | $1,315 | $55 |
| Losartan | 55 | $1,037 | $19 |
| Midodrine | 12 | $805 | $67 |
| Amlodipine Besylate | 91 | $784 | $9 |
| Carvedilol | 66 | $769 | $12 |
| Furosemide | 108 | $692 | $6 |
| Hydralazine | 29 | $672 | $23 |
| Famotidine | 54 | $600 | $11 |
| Lisinopril | 56 | $481 | $9 |
| Atorvastatin | 33 | $461 | $14 |
| Metoprolol | 20 | $338 | $17 |
| Omeprazole | 19 | $329 | $17 |
| Irbesartan-Hydrochlorothiazide | 11 | $327 | $30 |
| Clonidine | 22 | $313 | $14 |
| Levothyroxine | 18 | $284 | $16 |
| Doxazosin Mesylate | 23 | $280 | $12 |
| Gabapentin | 30 | $252 | $8 |
| Hydrochlorothiazide | 32 | $202 | $6 |
| Terazosin | 13 | $150 | $12 |
| Prednisone | 27 | $108 | $4 |
| Cephalexin | 18 | $62 | $3 |
2019: 41 drugs
| Sevelamer Carbonate | 126 | $82,522 | $655 |
| Renvela | 34 | $67,831 | $1,995 |
| Veltassa | 39 | $46,704 | $1,198 |
| Torsemide | 141 | $4,291 | $30 |
| Calcium Acetate | 45 | $3,979 | $88 |
| Clonidine | 15 | $3,675 | $245 |
| Calcitriol | 95 | $2,000 | $21 |
| Allopurinol | 96 | $1,706 | $18 |
| Midodrine | 16 | $1,638 | $102 |
| Carvedilol | 111 | $1,438 | $13 |
| Valsartan | 16 | $1,265 | $79 |
| Amlodipine Besylate | 108 | $1,123 | $10 |
| Furosemide | 157 | $1,123 | $7 |
| Hydralazine | 48 | $1,094 | $23 |
| Ranitidine | 35 | $878 | $25 |
| Potassium Chloride | 17 | $777 | $46 |
| Irbesartan | 24 | $774 | $32 |
| Atorvastatin | 37 | $743 | $20 |
| Nifedipine Er | 14 | $723 | $52 |
| Clonidine | 45 | $706 | $16 |
| Losartan | 70 | $698 | $10 |
| Gabapentin | 46 | $691 | $15 |
| Lisinopril | 73 | $638 | $9 |
| Metoprolol | 12 | $609 | $51 |
| Irbesartan-Hydrochlorothiazide | 13 | $450 | $35 |
| Doxazosin Mesylate | 20 | $434 | $22 |
| Minoxidil | 17 | $397 | $23 |
| Spironolactone | 21 | $383 | $18 |
| Omeprazole | 25 | $371 | $15 |
| Famotidine | 16 | $294 | $18 |
| Levothyroxine | 11 | $253 | $23 |
| Diltiazem 24hr Er (Cd) | 12 | $235 | $20 |
| Tamsulosin | 19 | $216 | $11 |
| Metoprolol | 22 | $181 | $8 |
| Ondansetron | 17 | $169 | $10 |
| Hydrochlorothiazide | 28 | $161 | $6 |
| Lactulose | 16 | $153 | $10 |
| Cephalexin | 27 | $150 | $6 |
| Simvastatin | 14 | $133 | $9 |
| Prednisone | 21 | $115 | $5 |
| Hydromorphone | 12 | $87 | $7 |
2018: 39 drugs
| Renvela | 52 | $82,761 | $1,592 |
| Sevelamer Carbonate | 72 | $65,396 | $908 |
| Veltassa | 39 | $41,375 | $1,061 |
| Calcium Acetate | 67 | $7,074 | $106 |
| Uloric | 11 | $5,686 | $517 |
| Potassium Citrate Er | 23 | $4,444 | $193 |
| Calcitriol | 146 | $3,473 | $24 |
| Torsemide | 107 | $2,872 | $27 |
| Midodrine | 16 | $1,896 | $118 |
| Potassium Chloride | 18 | $1,300 | $72 |
| Hydralazine | 39 | $1,151 | $30 |
| Valsartan | 24 | $1,117 | $47 |
| Allopurinol | 61 | $1,079 | $18 |
| Furosemide | 158 | $1,073 | $7 |
| Carvedilol | 91 | $979 | $11 |
| Amlodipine Besylate | 84 | $878 | $10 |
| Nifedipine Er | 11 | $777 | $71 |
| Clonidine | 55 | $730 | $13 |
| Ranitidine | 26 | $659 | $25 |
| Losartan | 64 | $599 | $9 |
| Kionex | 11 | $542 | $49 |
| Irbesartan | 13 | $395 | $30 |
| Omeprazole | 24 | $371 | $15 |
| Minoxidil | 15 | $355 | $24 |
| Gabapentin | 30 | $349 | $12 |
| Atorvastatin | 18 | $334 | $19 |
| Tamsulosin | 17 | $315 | $19 |
| Lisinopril | 49 | $291 | $6 |
| Ondansetron | 17 | $226 | $13 |
| Metoprolol | 11 | $222 | $20 |
| Polyethylene Glycol 3350 | 12 | $213 | $18 |
| Levofloxacin | 11 | $204 | $19 |
| Prednisone | 11 | $148 | $13 |
| Spironolactone | 16 | $138 | $9 |
| Hydrochlorothiazide | 21 | $131 | $6 |
| Cephalexin | 26 | $126 | $5 |
| Metoprolol | 15 | $112 | $7 |
| Simvastatin | 17 | $111 | $7 |
| Hydromorphone | 11 | $78 | $7 |
2017: 31 drugs
| Sensipar | 70 | $165,707 | $2,367 |
| Renvela | 61 | $96,885 | $1,588 |
| Veltassa | 19 | $19,676 | $1,036 |
| Calcium Acetate | 40 | $5,242 | $131 |
| Clinisol | 48 | $4,829 | $101 |
| Uloric | 12 | $4,749 | $396 |
| Potassium Citrate Er | 15 | $3,739 | $249 |
| Calcitriol | 103 | $2,668 | $26 |
| Clonidine | 12 | $2,461 | $205 |
| Torsemide | 53 | $1,912 | $36 |
| Nifedipine Er | 16 | $1,799 | $112 |
| Valsartan | 29 | $1,546 | $53 |
| Hydralazine | 60 | $1,470 | $24 |
| Clonidine | 55 | $953 | $17 |
| Potassium Chloride | 20 | $916 | $46 |
| Furosemide | 133 | $863 | $6 |
| Amlodipine Besylate | 85 | $828 | $10 |
| Allopurinol | 34 | $798 | $23 |
| Carvedilol | 81 | $729 | $9 |
| Lisinopril | 53 | $491 | $9 |
| Losartan | 43 | $485 | $11 |
| Gabapentin | 33 | $288 | $9 |
| Atorvastatin | 14 | $272 | $19 |
| Omeprazole | 18 | $268 | $15 |
| Spironolactone | 24 | $216 | $9 |
| Metoprolol | 26 | $208 | $8 |
| Hydrochlorothiazide | 16 | $138 | $9 |
| Ondansetron | 12 | $128 | $11 |
| Lactulose | 14 | $86 | $6 |
| Hydromorphone | 12 | $75 | $6 |
| Ranitidine | 11 | $38 | $3 |
2016: 25 drugs
| Renvela | 60 | $85,841 | $1,431 |
| Sensipar | 43 | $82,779 | $1,925 |
| Clinisol | 49 | $4,423 | $90 |
| Calcium Acetate | 31 | $4,335 | $140 |
| Clonidine | 14 | $3,435 | $245 |
| Nexium | 11 | $2,818 | $256 |
| Calcitriol | 92 | $2,092 | $23 |
| Torsemide | 46 | $1,784 | $39 |
| Hydralazine | 59 | $1,516 | $26 |
| Potassium Chloride | 29 | $1,430 | $49 |
| Valsartan | 16 | $1,354 | $85 |
| Clonidine | 59 | $1,097 | $19 |
| Carvedilol | 75 | $969 | $13 |
| Amlodipine Besylate | 100 | $796 | $8 |
| Lisinopril | 75 | $779 | $10 |
| Furosemide | 93 | $778 | $8 |
| Allopurinol | 25 | $685 | $27 |
| Losartan | 38 | $378 | $10 |
| Metoprolol | 23 | $196 | $9 |
| Gabapentin | 19 | $188 | $10 |
| Ondansetron | 19 | $142 | $7 |
| Spironolactone | 18 | $142 | $8 |
| Levofloxacin | 12 | $127 | $11 |
| Ranitidine | 11 | $91 | $8 |
| Hydrochlorothiazide | 12 | $67 | $6 |
2015: 21 drugs
| Sensipar | 33 | $48,856 | $1,480 |
| Renvela | 32 | $44,204 | $1,381 |
| Calcium Acetate | 20 | $2,925 | $146 |
| Valsartan | 15 | $1,958 | $131 |
| Potassium Chloride | 25 | $1,669 | $67 |
| Hydralazine | 65 | $1,320 | $20 |
| Clonidine | 71 | $1,092 | $15 |
| Carvedilol | 86 | $954 | $11 |
| Amlodipine Besylate | 109 | $910 | $8 |
| Furosemide | 78 | $786 | $10 |
| Torsemide | 29 | $775 | $27 |
| Allopurinol | 26 | $644 | $25 |
| Calcitriol | 37 | $537 | $15 |
| Lisinopril | 42 | $345 | $8 |
| Spironolactone | 16 | $296 | $19 |
| Zolpidem | 13 | $280 | $22 |
| Hydroxyzine | 23 | $267 | $12 |
| Omeprazole | 16 | $224 | $14 |
| Hydrochlorothiazide | 36 | $210 | $6 |
| Losartan | 29 | $198 | $7 |
| Gabapentin | 20 | $141 | $7 |
2014: 15 drugs
| Sensipar | 17 | $19,859 | $1,168 |
| Calcium Acetate | 19 | $2,629 | $138 |
| Potassium Chloride | 43 | $2,581 | $60 |
| Carvedilol | 61 | $874 | $14 |
| Amlodipine Besylate | 56 | $632 | $11 |
| Torsemide | 26 | $533 | $20 |
| Clonidine | 45 | $522 | $12 |
| Hydralazine | 18 | $405 | $22 |
| Spironolactone | 11 | $321 | $29 |
| Furosemide | 42 | $310 | $7 |
| Allopurinol | 21 | $220 | $10 |
| Hydrochlorothiazide | 26 | $198 | $8 |
| Losartan | 12 | $185 | $15 |
| Lisinopril | 18 | $158 | $9 |
| Prednisone | 13 | $145 | $11 |
2013: 2 drugs
| Carvedilol | 19 | $290 | $15 |
| Amlodipine Besylate | 17 | $176 | $10 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 1 | 1 | None | $64 |
| 2022 | 3 | 3 | None | $104 |
| 2020 | 1 | 1 | None | $124 |
| 2019 | 3 | 6 | None | $599 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calliditas Therapeutics US | Tarpeyo | $125 | 1 payment
|
See the published payment
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $125 |
See earlier years (2024, 2022, 2020, 2019)
2024: $64
| Calliditas Therapeutics US | Tarpeyo | $64 | 1 payment
|
2022: $104
| Amgen | Tavneos | $55 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $37 | 1 payment
|
| Vifor Pharma | None | $12 | 1 payment
|
2020: $124
| AstraZeneca Pharmaceuticals LP | None | $124 | 1 payment
|
2019: $599
| Fresenius USA Marketing | Velphoro | $426 | 4 payments
|
| Bard Peripheral Vascular | None | $150 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $22 | 1 payment
|
Professional record
- NPI
- 1770779431
- Licence
- CA A121507, MA 242709California A121507: Current · expires 2028-04-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2007-09-17
- NPI last updated
- 2015-07-03
This is when the NPI record was last certified, not a medical board exam.